E-LIB Suche - Ergebnisse für: Frias, Juan P.

1

CATALYST: A Phase 4 Study of Hypercortisolism in Patients w..:

Frias, Juan P. ; Auchus, Richard J. ; Bancos, Irina...
American Heart Journal. 267 (2024) - p. 134-135 , 2024

2

Tirzepatide Improved Markers of Islet Cell Function and Ins..:

Frias, Juan P ; De Block, Christophe ; Brown, Katelyn...
The Journal of Clinical Endocrinology & Metabolism. 109 (2024) 7 - p. 1745-1753 , 2024

Link: https://doi.org/10.1210/..

3

BMF-219: A Novel Therapeutic Agent to Reestablish Functiona..:

Frias, Juan P. ; Mourya, Sanchita ; Munneke, Brian...
Metabolism. 153 (2024) - p. 155884 , 2024

Link: https://doi.org/10.1016/..

4

Safety and Efficacy of Efruxifermin in Combination With a G..:

Harrison, Stephen A. ; Frias, Juan P. ; Lucas, K. Jean...
Clinical Gastroenterology and Hepatology. , 2024

Link: https://doi.org/10.1016/..

5

LBO-002 Efruxifermin significantly reduced liver fibrosis i..:

Harrison, Stephen A. ; Frias, Juan P ; Neff, Guy...
Journal of Hepatology. 80 (2024) - p. S8 , 2024

Link: https://doi.org/10.1016/..

6

Triple hormone receptor agonist retatrutide for metabolic d..:

Sanyal, Arun J. ; Kaplan, Lee M. ; Frias, Juan P....
Nature Medicine. 30 (2024) 7 - p. 2037-2048 , 2024

Link: https://doi.org/10.1038/..

7

Study protocol for a prospective, multicentre study of hype..:

DeFronzo, Ralph A ; Auchus, Richard J ; Bancos, Irina...
BMJ Open. 14 (2024) 7 - p. e081121 , 2024

Link: https://doi.org/10.1136/..

8

Tolerability, safety and pharmacodynamics of oral, small‐mo..:

Saxena, Aditi R. ; Frias, Juan P. ; Gorman, Donal N....
Diabetes, Obesity and Metabolism. 25 (2023) 10 - p. 2805-2814 , 2023

Link: https://doi.org/10.1111/..

9

Non-invasive tests of liver injury, inflammation and fibros..:

Schattenberg, Jörn ; Frias, Juan P ; Neff, Guy...
Journal of Hepatology. 78 (2023) - p. S808-S809 , 2023

Link: https://doi.org/10.1016/..

10

Pegozafermin Led to Significant Metabolic Benefits, in Addi..:

Alkhouri, Naim ; Loomba, Rohit ; Frias, Juan P....
Metabolism. 142 (2023) - p. 155455 , 2023

Link: https://doi.org/10.1016/..

11

Efficacy and safety of oral orforglipron in patients with t..:

Frias, Juan P ; Hsia, Stanley ; Eyde, Sarah...
The Lancet. 402 (2023) 10400 - p. 472-483 , 2023

Link: https://doi.org/10.1016/..

12

A microbiome‐targeting fibre‐enriched nutritional formula i..:

Frias, Juan P. ; Lee, Martin L. ; Carter, Matthew M....
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1203-1212 , 2023

Link: https://doi.org/10.1111/..

13

Pegozafermin for the treatment of non-alcoholic steatohepat..:

Loomba, Rohit ; Sanyal, Arun ; Kowdley, Kris...
Journal of Hepatology. 78 (2023) - p. S14-S15 , 2023

Link: https://doi.org/10.1016/..

14

Cardiovascular efficacy and safety of antidiabetic agents: ..:

Sohn, Minji ; Frias, Juan P. ; Lim, Soo
Diabetes, Obesity and Metabolism. 25 (2023) 12 - p. 3560-3577 , 2023

Link: https://doi.org/10.1111/..

15

Tirzepatide once weekly for the treatment of obesity in peo..:

Garvey, W Timothy ; Frias, Juan P ; Jastreboff, Ania M...
The Lancet. 402 (2023) 10402 - p. 613-626 , 2023

Link: https://doi.org/10.1016/..